Evidence map›Paper›PMID 41320720›Full record

ArticleBritish journal of haematology2026

Clinical outcomes and safety in patients with lower-risk myelodysplastic syndromes treated with imetelstat: Substudy of the phase 3 IMerge trial.

Rami S Komrokji, Valeria Santini, Uwe Platzbecker, Koen Van Eygen, María Díez-Campelo, Raquel de Paz, Guillermo Sanz Santillana, Sylvain Thépot, Maciej Kaźmierczak, Esther Natalie Oliva and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Rami S KomrokjiMoffitt Cancer Center, Tampa, Florida, USA.
Valeria SantiniMDS Unit, Hematology, DMSC University of Florence, AOUC, Florence, Italy.
Uwe PlatzbeckerNational Center for Tumor Diseases (NCT), University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
Koen Van EygenAZ Groeninge, Kortrijk, Belgium.
María Díez-CampeloUniversity Hospital of Salamanca, IBSAL, Universidad de Salamanca, Salamanca, Spain.
Raquel de PazServicio de Hematología y Hemoterapia, Hospital Universitario La Paz, Madrid, Spain.
Guillermo Sanz SantillanaHospital Universitario y Politécnico La Fe, Valencia, Spain.
Sylvain ThépotCentre Hospitalier Universitaire d'Angers, Angers, France.
Maciej KaźmierczakPoznań University of Medical Sciences, Poznań, Poland.
Esther Natalie OlivaLondon North West University Healthcare NHS Trust, London, UK.
Mikkael A SekeresSylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA.
Pierre FenauxHôpital Saint-Louis, Université de Paris 7, Paris, France.
Yazan F MadanatHarold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA.
Michael R SavonaVanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Jennifer RiggsGeron Corporation, Foster City, California, USA.
Sheetal ShahGeron Corporation, Foster City, California, USA.
Ashley L LennoxGeron Corporation, Foster City, California, USA.
Qi XiaGeron Corporation, Foster City, California, USA.
Libo SunGeron Corporation, Foster City, California, USA.
Tymara BerryGeron Corporation, Foster City, California, USA.
Amer M ZeidanYale School of Medicine and Yale Cancer Center, Yale University, New Haven, Connecticut, USA.

Funding

Geron Corporation
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anaemiaclinical trialefficacyimetelstatmyelodysplastic syndromesQTcsafetytransfusions

Identifiers

PMID41320720
PMCPMC12916184

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.